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Abstract
Large-scale cross-sectional and cohort studies have transformed our understanding of
the genetic and environmental determinants of health outcomes. However, the represen-
tativeness of these samples may be limited–either through selection into studies, or by
attrition from studies over time. Here we explore the potential impact of this selection
bias on results obtained from these studies, from the perspective that this amounts to
conditioning on a collider (i.e. a form of collider bias). Whereas it is acknowledged that
selection bias will have a strong effect on representativeness and prevalence estimates,
it is often assumed that it should not have a strong impact on estimates of associations.
We argue that because selection can induce collider bias (which occurs when two vari-
ables independently influence a third variable, and that third variable is conditioned
upon), selection can lead to substantially biased estimates of associations. In particular,
selection related to phenotypes can bias associations with genetic variants associated
with those phenotypes. In simulations, we show that even modest influences on selec-
tion into, or attrition from, a study can generate biased and potentially misleading esti-
mates of both phenotypic and genotypic associations. Our results highlight the value of
knowing which population your study sample is representative of. If the factors influenc-
ing selection and attrition are known, they can be adjusted for. For example, having DNA
available on most participants in a birth cohort study offers the possibility of investigat-
ing the extent to which polygenic scores predict subsequent participation, which in turn
would enable sensitivity analyses of the extent to which bias might distort estimates.
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Introduction
Understanding the impact of genetic and environmental
factors on physical and mental health outcomes is critical
if we are to develop effective preventive and treatment
interventions. Large-scale cross-sectional and cohort stud-
ies provide an invaluable resource to support these efforts,
in particular with respect to genetic influences where the
small effects associated with common genetic variants re-
quire very large samples to achieve adequate statistical
power. A study can be used to draw conclusions about the
population it represents (the “intended study population”),
but generalizability to other populations depends upon us
knowing exactly what the actual study population is.
However, participants who volunteer to participate in
studies may not be representative of the intended study
population, in which case the actual study population is
unknown.1
Some studies may be relatively representative of the in-
tended study population at inception through rigorous ef-
forts to ensure representative recruitment (e.g. birth cohort
studies). However, as they mature the likelihood is that at-
trition from the study will be non-random, so that the co-
hort becomes less representative of the intended
population as time goes on. Alternatively, the reverse may
be true—the study may be unrepresentative at inception,
but with low attrition. Selection bias can also occur if a
sub-set of participants within a study is selected for more
detailed investigation (e.g. genotyping) on the basis of
having most data available or volunteering for further fol-
low-up.2 There is already clear evidence from existing
large-scale population studies that they are subject to a de-
gree of selection bias. For example, higher genetic risk
scores for schizophrenia are consistently associated with
non-completion of questionnaires by study mothers and
children, as well as non-attendance at data collection clin-
ics, in the Avon Longitudinal Study of Parents and
Children (ALSPAC)3 (see Box 1).
Attrition from cohort studies may result in biased esti-
mates of socioeconomic inequalities, and the degree of bias
may worsen as participation rates decrease.4 However, it is
often argued that representativeness is not necessary in
studies of this kind,5–9 although this is not universally
accepted.10 In particular for genetic variants, where con-
ventional confounding is low,11 it has been argued even by
those concerned about selection bias that any problems
associated with a lack of representativeness may be mod-
est.10,12 Here we ask: what is the impact of selection bias
on the results obtained from these studies? We take the
perspective that selection bias can amount to conditioning
on a collider (i.e. conditioning on a variable that is inde-
pendently influenced by two other variables).
Collider bias
It is widely acknowledged that selection bias will distort
prevalence estimates. This can be clearly seen in differences
between participants at baseline and at subsequent assess-
ments in cohort studies, such as when we compare the ori-
ginal ALSPAC sample with those who attended later
clinics (see Box 1). It can also be seen in differences be-
tween an actual study sample and the source population
from which it is drawn (i.e., the intended study popula-
tion); for example, the UK Biobank study differs relative to
the general population in the UK (see Box 2). However, it
is often assumed that although selection bias will have a
strong effect on prevalence estimates, it should not have a
strong impact on observed associations between variables.8
This overlooks the fact that selection can induce collider
bias (see Figure 1), which can lead to biased observational
and genetic associations. This bias can be towards or away
from any true association, and can distort a true associ-
ation or a true lack of association.
Collider bias occurs when two variables (X and Y) inde-
pendently cause a third variable (Z). In this situation Z is a
collider, and statistical adjustment for Z will bias the esti-
mated causal association of X (exposure) on Y (outcome)
(see Figure 2). Statistical adjustment of the XY association
for a variable Z is equivalent to observing this association
in a sub-population where all individuals share the same
value of Z.1,13 Hence if both X and Y cause participation
in a study (Z), then investigating associations in the se-
lected sample (i.e. with Z¼ 1, indicating participation in
the study) is equivalent to conditioning on Z, which in turn
may induce collider bias.
Key Messages
• Selection bias (including selective attrition) may limit the representativeness of large-scale cross-sectional and cohort
studies.
• This selection bias may induce collider bias (which occurs when two variables independently influence a third vari-
able, and that variable is conditioned upon).
• This may lead to substantially biased estimates of associations, including of genetic associations, even when selec-
tion/attrition is relatively modest.
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In other words, sample selection can bias associations
between variables that influence participation or retention
in a study. This can include inducing spurious associations
when no such association exists in the intended study pop-
ulation or, if two variables are correlated in the intended
study population and both cause selection, biasing the esti-
mated correlation in the selected sample. Moreover, this
selection bias will apply to the genetic correlates (or other
ancestors) of these variables, unless the phenotypes are
also controlled for. Therefore if genes Gx and Gy cause X
(exposure) and Y (outcome), respectively, and both X and
Y influence participation, then in the selected sample Gx
will appear to be associated with Y (unless X is also con-
trolled for). More complex situations can also give rise to
collider bias, such as when the outcome (Y) does not dir-
ectly cause selection into the study (i.e. it is a downstream
consequence of something else that is causing selection into
the study).
If two traits influence participation (and therefore con-
tribute to selection), selection bias amounts to implicitly
Box 1 The Avon Longitudinal Study of Parents and Children
Birth cohort studies are not immune to problems of selection bias, where retention in the study may be related to a var-
iety of participant characteristics. The Avon Longitudinal Study of Parents and Children (ALSPAC) recruited pregnant
women living in the administrative county of Avon, with expected delivery dates between 1 April 1991 and 31
December 1992. These women, their partners and their offspring have been followed up ever since via questionnaires
and clinics. ALSPAC originally captured data on 14 541 pregnancies (75% of eligible women) (19, 36), but inevitably re-
tention in subsequent data collection sweeps (postal questionnaires and clinic assessments) was less than 100%. We
see that higher body mass index (BMI) is associated with lower odds of subsequent retention in both mothers (N¼11
319, OR per SD increase in BMI 0.85, 95% CI 0.81 to 0.88), for retention between 2008 and 2011 using pre-pregnancy
BMI as a predictor, and offspring (N¼ 7954, OR 0.91, 95% CI 0.87 to 0.96), for retention at age 18 using BMI at age 7 as
a predictor. Similarly, among smoking mothers in ALSPAC, heaviness of smoking is associated with lower odds of re-
tention (N¼3534, OR per additional cigarette smoked per day just prior to pregnancy 0.97, 95% CI 0.96 to 0.98). If low
BMI and maternal non-smoking are both related to continuing participation in ALSPAC, this would tend to lead to the
association between BMI and maternal smoking being negatively biased (i.e. we would expect to see a more negative
association between smoking and BMI in ALSPAC than in the intended study population).
Box 2 UK Biobank
The UK Biobank is a cross-sectional study which recruited over 500 000 individuals aged between 40 and 69 years be-
tween 2006 and 2010 [http://www.ukbiobank.ac.uk/]. Individuals in this age group living within a 25-mile radius of any
of the 22 assessment centres across the UK were identified from NHS patient registers.37 In total, around 9 million indi-
viduals were invited to participate. However, UK Biobank was only able to achieve a 5% response rate (500 000
participants recruited from 9 000 000 invited, personal communication, UK Biobank, 8 July 2016), and the resulting
sample is not representative of the UK population as a whole. For example, the proportion of current smokers is rela-
tively low in UK Biobank (19% in the general population vs 11% in UK Biobank, equivalent to an OR of 1.90),38 as is the
proportion with no qualifications (25% vs 17%, equivalent to an OR of 1.63).39 Unsurprisingly, therefore, participants in
UK Biobank have far lower rates of 5-year mortality than the UK population as a whole.40 Clearly, agreeing to take part
in the UK Biobank study is associated with a number of characteristics that will reflect, for example, health status and
social position. If non-smoking and having qualifications are both causally related to participation in UK Biobank, we
would expect the association between smoking and having qualifications to be positively biased (i.e. we would expect
to see a more positive association between genetic variants positively associated with smoking and whether partici-
pants had educational qualifications in UK Biobank than in the UK population). The problem is possibly compounded in
genetic studies using the first release of genome-wide association data in UK Biobank, which used two genotyping
arrays, one of which was applied to a nested case-control study of smoking and lung function (UK BiLEVE).41 The first
release genetic data are therefore further subject to selection bias relative to UK Biobank as a whole (although this will
no longer be the case when the full release of genome-wide association data becomes available).
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conditioning on their common effect (i.e. participa-
tion).1,14 This can in principle lead to biased associations
between these two traits. There are exceptions to this, de-
pending on the distribution of the outcome and the para-
metric analysis model used. For example, if the outcome
(Y) is a binary phenotype, and logistic regression is used,
then the odds ratio for the association between the single
nucleotide polymorphism (SNP) and outcome may be un-
biased even when the outcome causes selection (as is true
of case-control studies).15 We have previously argued that
these effects may be greater in case-control studies than
prospective studies, and that since genetic associations
have been similar across study designs, the impact of selec-
tion bias may in fact be modest.12 We have also previously
argued that because conventional confounding is typically
low for single genetic variants, problems of selection bias
will be less in this context.10 However, given the rapid
growth in studies using data from highly selected samples
such as UK Biobank, and the use of genetic risk scores ra-
ther than single genetic variants, we revisited this question
and used simulation to explore the potential impact of
even relatively weak effects on participation. Given empir-
ical evidence of selection in cross-sectional and cohort
studies, what is the potential impact of this on observed
phenotypic and genotypic associations?
Simulations
We simulated data on an allele score, a phenotype and an
outcome, where both the phenotype and the outcome in-
fluence selection into the study, but there was no associ-
ation between the allele score and the outcome in the
intended study population (see Figure 2). The simulation
scenario was based loosely on the UK Biobank, and we
simulated selection into the study, so all the data on non-
selected individuals are missing and therefore imputation is
not a potential solution (see below), because this requires
some data on which to base the imputation.16 All variables
were Normally distributed, with a standard deviation of 1,
and the sample size of the intended study population was 9
000 000. We assumed that phenotype and outcome had in-
dependent effects (i.e. no interaction on the additive scale)
on the odds of selection into the sample, and for conveni-
ence we set these effects to be equal, and examined a weak
association [odds ratio (OR) of 1.2 for missingness for a
one standard deviation (SD) increase in phenotype/out-
come] and two stronger associations (ORs of 1.5 and 1.8).
These odds ratios are similar to estimates of the likelihood
of participation in UK Biobank for individuals with any
educational or vocational qualifications and for non–
smokers, respectively (see Box 2), and indicate a difference
in mean phenotype/outcome of 0.2 SD, 0.4 SD and 0.6 SD
between those participating and those not participating.
We varied the correlation between the allele score and the
phenotype (between r¼ 0.05 and r¼ 0.30) to simulate gen-
etic instruments explaining between 0.25% and 9% of the
variance in phenotypes. These values are in the typical
range for the association between common genetic vari-
ants, or polygenic risk scores comprising multiple common
variants, and complex phenotypes. For example, the
rs16969968 variant accounts for approximately 1% of the
phenotypic variance in cigarette consumption,17 whereas
the polygenic risk score for height captures approximately
9% of phenotypic variance.18 We controlled the baseline
risk of selection into the sample, resulting in a selected
sample of approximately 500 000 people. The analysis was
Coin Toss
Bell
Coin Toss
Coin Toss
Bell
Coin Toss
r = -0.5
Figure 1. Illustration of collider bias. The basic premise of collider bias
is shown. In this example, a bell is sounded whenever either coin come
up ‘heads’. The result of one coin toss is independent of the other.
However, if we hear the bell ring (i.e. we condition on the bell ringing),
then if we see a tail on one coin we know there must be a head on the
other–the two coin results are no longer independent and a spurious in-
verse correlation has been induced. Reproduced from Gage SH, Davey
Smith G, Ware JJ, Flint J, Munafo` MR. G¼E: What GWAS can tell us
about the environment. PLoS Genet 2016;12: e1005765.
Phenotype (X) Outcome (Y) Allele score 
Selection into 
Study (Z) 
Figure 2. Illustration of selection bias simulation. In the intended study
population there is no association between allele score and outcome.
Selection into the study (either through voluntary participation at base-
line, or attrition over time) induces an association between allele score
and outcome (collider bias).
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an unadjusted regression of outcome on allele score (i.e.
not adjusting for the phenotype). We simulated a true null
association (i.e. in the intended study population, the re-
gression coefficient for outcome on allele score is zero). We
simulated each scenario 100 times. We then repeated the
simulations with the addition of a causal effect of the
phenotype on the outcome, with a regression coefficient of
0.1.
The results of this simulation study are shown in Table 1
(no causal effect of P on O) and Table 2 (causal effect of P
on O). Where there is no causal effect of P on O, the effects
of selection bias are strongest for stronger independent se-
lection effects, and also where the allele score is more
strongly associated with the phenotype (Table 1). However,
even for moderate associations between missingness and
both phenotype and outcome (OR¼ 1.5 for both pheno-
type and outcome) and between allele score and phenotype
(r¼ 0.1, 1% variance explained by allele score) the confi-
dence intervals contain zero only 89% of the time, and this
continues to decrease with both greater strength of associ-
ation between phenotype, outcome and missingness, and
stronger association between allele score and phenotype.
Where there is a causal effect of P on O, the results are
broadly similar, except that on the whole the confidence
intervals had lower coverage than for the equivalent situ-
ation with no causal association.
Table 1. Results of simulation study showing the selection bias in estimating an association that is null in the intended study
population
Simulation settings Results—association between allele score and outcome
Association be-
tween missing-
ness and both
phenotype and
outcome (OR)
Association be-
tween allele score
and phenotype
(r)
Mean regression
coefficient (SD)
Mean z-score (SD) Number of
95% CIs con-
taining zero
OR¼1.8 0.05 0.001 (0.001) 1.04 (1.00) 83
(0.25% variance)
0.10 0.003 (0.001) 2.06 (0.98) 45
(1.00% variance)
0.15 0.004 (0.001) 3.07 (0.98) 9
(2.25% variance)
0.20 0.006 (0.001) 4.10 (0.98) 0
(4.00% variance)
0.30 0.008 (0.001) 6.18 (1.06) 0
(9.00% variance)
OR¼1.5 0.05 0.001 (0.001) 0.42 (0.95) 94
(0.25% variance)
0.10 0.001 (0.001) 0.80 (0.96) 89
(1.00% variance)
0.15 0.001 (0.001) 1.22 (0.96) 77
(2.25% variance)
0.20 0.002 (0.001) 1.64 (0.97) 61
(4.00% variance)
0.30 0.003 (0.001) 2.44 (0.94) 35
(9.00% variance)
OR¼1.2 0.05 0.0002 (0.001) 0.16 (0.92) 97
(0.25% variance)
0.10 0.0003 (0.001) 0.25 (0.94) 97
(1.00% variance)
0.15 0.0005 (0.001) 0.38 (0.95) 93
(2.25% variance)
0.20 0.0006 (0.001) 0.47 (0.95) 91
(4.00% variance)
0.30 0.0009 (0.001) 0.66 (0.96) 89
(9.00% variance)
Each scenario was simulated 100 times.
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We also explored associations between known risk
factors and outcomes in a representative birth cohort and
a selected sub-study. We used ALSPAC as the birth
cohort. Initially, 14 541 pregnant women who were
expected to give birth between 1 April 1991 and 31
December 1992 were recruited into the study in the
South West region of England.19 The study website con-
tains details of all data available through a fully search-
able data dictionary: [http://www.bris.ac.uk/alspac/
researchers/data-access/data-dictionary/]. Ethics approval
for the study was obtained from the ALSPAC Ethics and
Law Committee and the local research ethics committees.
We also used the Accessible Resource for Integrated
Epigenomics Studies (ARIES), a sub-study of ALSPAC
where a sub-set of 1018 mother-offspring pairs were se-
lected based on availability of DNA samples at two time
points for the mother (at an antenatal clinic and at a
follow-up clinic when their offspring were mean age 15.5
years) and three time points for the offspring (at birth,
childhood and adolescence.2 We investigated the associ-
ation between a genetic risk score for smoking (ever vs
never) and maternal education in ALSPAC, and in the
ARIES sub-sample. The results are shown in Table 3, and
indicated that the genetic risk score for smoking and ma-
ternal education are associated in ARIES, but not in the
full sample.
Table 2. Results of simulation study showing the selection bias in estimating an association that is not null in the intended study
population (regression coefficient for outcome on phenotype is 0.1)
Simulation settings Results—association between allele score and outcome
Association be-
tween missing-
ness and both
phenotype and
outcome (OR)
Association be-
tween allele score
and phenotype
(r)
Mean regression
coefficient (SD)
True regression
coefficient
Number of
95% CIs con-
taining true
value
OR¼1.8 0.05 0.003 (0.001) 0.005 78
(0.25% variance)
0.10 0.006 (0.001) 0.01 23
(1.00% variance)
0.15 0.010 (0.001) 0.015 2
(2.25% variance)
0.20 0.013 (0.001) 0.02 0
(4.00% variance)
0.30 0.020 (0.001) 0.03 0
(9.00% variance)
OR¼1.5 0.05 0.004 (0.001) 0.005 94
(0.25% variance)
0.10 0.009 (0.001) 0.01 86
(1.00% variance)
0.15 0.013 (0.001) 0.015 69
(2.25% variance)
0.20 0.017 (0.001) 0.02 53
(4.00% variance)
0.30 0.026 (0.001) 0.03 19
(9.00% variance)
OR¼1.2 0.05 0.005 (0.001) 0.005 98
(0.25% variance)
0.10 0.01 (0.001) 0.01 96
(1.00% variance)
0.15 0.014 (0.001) 0.015 94
(2.25% variance)
0.20 0.019 (0.001) 0.02 92
(4.00% variance)
0.30 0.029 (0.001) 0.03 95
(9.00% variance)
Each scenario was simulated 100 times.
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Conclusions
Our results indicate the potential for selection/attrition to
generate biased and potentially misleading estimates of
both phenotypic and genotypic associations. In particular,
when polygenic scores (associated with a phenotype) that
combine many genetic variants are used, association be-
tween the phenotype and participation will cause the score
to be more strongly related to participation than each indi-
vidual variant is. This, in turn, can potentially lead to ser-
ious bias. For this reason, studies using polygenic scores,
genome-wide allelic scores20 and/or whole-genome genetic
correlations21,22 are most at risk of producing biased and
potentially misleading results where there is reason to be-
lieve the actual study sample is not representative of the
intended study population, but the mechanism of selection
is unknown.
The magnitude of effects we observed in our simula-
tions, based on credible estimates of associations between
both a phenotype or outcome and missingness, and be-
tween a polygenic score and a phenotype, are comparable
to many reported associations derived from large but se-
lected samples, such as between personality and cognitive
function, and a range of physical and mental health out-
comes,23,24 and between chronotype (i.e. ‘morningness’)
and years of education.25 Such associations could therefore
plausibly be generated by selection bias. An appreciation
of the potential impact of selection bias may also resolve
inconsistencies in the literature, and help to explain appar-
ently paradoxical findings. For example, genetic correl-
ations between cognitive ability and a range of psychiatric
disorders have been reported to differ in childhood and
older age.26 One possible interpretation is that this is due
to age-dependent pleiotropy, but another is that this is an
artefact of different selection bias pressures at different
ages. An example serves to illustrate this. Polygenic risk
scores that maximally capture schizophrenia liability are
associated with increased psychotic experiences in
ALSPAC participants, but scores that use more stringent
thresholds for including genetic variants are associated
with reduced psychotic experiences.27 Since missing data
are likely to be greater for participants who report psych-
otic experiences, as well as for those at higher genetic risk
of a psychotic disorder, psychotic experiences may be rela-
tively under-represented in participants with higher genetic
risk, compared with those with lower genetic risk.27
Such collider bias could occur through initial selection,
or selective drop-out, or both–for example, a study could
be representative of its intended population initially, but
become less representative as those of poorer health drop
out due to death. The main difference between these two
scenarios–initial selection and selection through attrition–
is in the amount of information available on the missing in-
dividuals. Where some data are available for all partici-
pants (e.g. in the case of drop-out), then multiple
imputation or inverse probability weighting can be used28
under some assumptions which are untestable given the
observed data, to recover unbiased estimates of associ-
ations. However, where there is no information on missing
individuals (e.g. we have no data on individuals who did
not volunteer for participation into a study), then such
methods cannot be used. External information (such as the
expected proportion of males and females in the general
Table 3. Associations between a genetic risk score for smoking and maternal education, in ALSPAC and ARIES
Association between genetic risk score and ever smoking in ALSPAC
N OR (95% CI) P
Smoking genetic risk score 1 7291 1.07 (1.02 to 1.12) 0.003
Association with being in the ARIES sub-study
N OR (95% CI) P
Smoking (ever vs never) 13249 0.59 (0.52 to 0.68) <0.001
Smoking genetic risk scorea 7837 1.00 (0.93 to 1.07) 0.92
Maternal educationb 12493 1.86 (1.58 to 2.19) <0.001
Association between smoking/smoking genetic risk score and maternal education in ALSPAC and ARIES
ALSPAC N OR (95% CI) P
Smoking (ever vs never) 12118 0.45 (0.40 to 0.50) <0.001
Smoking genetic risk scorea 7046 1.01 (0.95 to 1.08) 0.74
ARIES N OR (95% CI) P
Smoking (ever vs never) 986 0.61 (0.44 to 0.84) 0.003
Smoking genetic risk scorea 791 1.20 (1.02 to 1.41) 0.03
aGenetic risk score including variants reaching P< 0.05 for association with ever vs never smoking in the Tobacco and Genetics Consortium GWAS (see
Supplementary Material, available at IJE online). Associations are per SD increase in genetic risk score.
bDegree vs no degree.
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population) could be used to investigate likely factors
related to participation and to derive bias-adjusted
estimates.
A related issue is the use of case-control studies to
examine associations with ‘secondary’ outcomes–that is,
phenotypes other than the case/control outcome.29,30 In
such studies, the association between genotype and second-
ary phenotype will be biased if both genotype and second-
ary phenotype are associated with case-control status.
Case-control studies condition on case-control status, and
thus again collider bias can bias the association between
genotype and secondary phenotype. Various methods have
been proposed to overcome this bias, including maximum
likelihood and inverse probability weighting. This latter
method requires some knowledge about the prevalence of
case/control status in the intended study population, or the
assumption that the disease is rare.29,30
We have discussed one important way in which selec-
tion into or out of a study can induce collider bias and
spurious associations. There are other ways in which ascer-
tainment can generate biases.31 For example, Figure 3
(panel B) shows a situation in which entry into a study is
conditional upon the value of the phenotype (but not the
outcome of interest) and where the phenotype does not
cause the outcome, but the phenotype and outcome are
correlated in unselected samples (i.e. due to genetic and/or
environmental factors U). In this situation, collider bias
occurs because conditioning on selection induces an associ-
ation between SNPs related to the phenotype and the poly-
genic and/or environmental factors that influence the
outcome. Therefore, SNPs that cause the phenotype only
(i.e. do not in truth cause the outcome) may now show
spurious relationships with the outcome variable. An ex-
ample of the situation in Figure 3 (panel B) is when the
phenotype increases mortality32–35–for example, in studies
of smoking as a phenotype, where smoking is associated
with premature mortality. In a cohort study which exam-
ines smoking, and then follows participants up for
Alzheimer’s disease, those who die early (perhaps because
of smoking-related illness) will never have the chance to be
diagnosed with Alzheimer’s disease, and therefore smoking
will appear to be a protective factor. Figure 3 (panels C to
E) also shows examples where selection will bias the esti-
mation of the causal effects of SNPs on the outcome. In
these examples, SNPs that do cause the outcome directly
via the phenotype will show either increased or decreased
association in the selected sample, depending on the under-
lying genetic and environmental aetiology of both traits. In
the situations depicted in Figure 3A, C and E, the associ-
ation between phenotype and outcome (e.g. in an observa-
tional study) would also be biased. In contrast, Figure 3F
Figure 3. Scenarios where selection bias would occur. A. In truth, the
SNP is not causally associated with the outcome; selection will induce
an association (which could be positive or negative). B. In truth, the
SNP is not causally associated with the outcome; selection will induce
an association (which could be positive or negative). C. In truth, the
SNP is causally associated with the outcome; selection could make this
larger or attenuate it. D. In truth, the SNP is causally associated with the
outcome; selection could make this larger or attenuate it. E. In truth, the
SNP is causally associated with the outcome; selection will bias this as-
sociation (which could be positive or negative). F. Note that the associ-
ation between P and O is biased in the selected sample; however, the
association between SNP and O is unbiased in the selected sample. P,
Phenotype; O, Outcome; S, Selection; U, Other variables.
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shows a situation where selection will bias the association
of the phenotype with the outcome, but the association of
the SNP with the outcome will be unbiased. Other, more
complex, situations can also lead to selection bias—we
have not attempted to outline every possible case here.
Algorithms for deciding whether a given causal analysis is
biased by selection have been described,16 and could be
used to decide whether bias is likely in a given case.
Our results highlight the value of representative cohorts
(including birth cohorts) where there is little or no selection
into the cohort. The issue of whether the study is intended
to be representative in the first place is a somewhat sepa-
rate issue, albeit a related one (see Box 3). In addition, hav-
ing some baseline data and DNA available on all
participants at recruitment into the study at least offers the
possibility of investigating the extent to which polygenic
scores (and other measured factors at baseline) predict sub-
sequent participation. Without this knowledge, studies in
samples with unknown selection/attrition mechanisms run
the risk of providing biased and misleading results. In our
opinion these important caveats should be borne in mind
when interpreting the results of such studies.
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